The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study

BACKGROUND: Beta-blockers can reduce recurrence, metastasis, and mortality in various cancers. In this study, we investigated the effect of propranolol, a non-selective beta-blocker on overall survival (OS) in unresectable/metastatic hepatocellular carcinoma (HCC) and on recurrence-free survival (RF...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ping-Ying, Chung, Chi-Hsiang, Chang, Wei-Chou, Lin, Chun-Shu, Lin, Hsuan-Hwai, Dai, Ming-Shen, Ho, Ching-Liang, Chien, Wu-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534323/
https://www.ncbi.nlm.nih.gov/pubmed/31125347
http://dx.doi.org/10.1371/journal.pone.0216828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534323/
https://www.ncbi.nlm.nih.gov/pubmed/31125347
http://dx.doi.org/10.1371/journal.pone.0216828

Ejemplares similares